![](https://images.squarespace-cdn.com/content/v1/611d0b86ac3d720667702939/41e8be4e-9d25-41a6-9a8c-9aa96857906b/Circle_banner-03.jpg)
Meet us at AAIC in Philadelphia from July 28 to August 1, 2024
Leading an Unprecedented Global Response to Alzheimer's
We are uniting leading organizations worldwide to build an innovation ecosystem that will accelerate breakthroughs, develop and scale promising solutions and equip every healthcare system to end Alzheimer's disease everywhere.
![](https://images.squarespace-cdn.com/content/v1/611d0b86ac3d720667702939/25220486-d9f6-4508-9a6b-9cc92c91f6c0/Dots_lines_banner-01.png)
The Challenge
3x
By 2050, the number of people living with dementia will triple to 139 million.
75%
Globally, 3 out of 4 people with dementia are never even diagnosed, much less treated.
$1.3 trillion
Every year, dementia costs the global economy more than $1.3 trillion. This number will increase by up to nine times from 2020 to 2050.
![](https://images.squarespace-cdn.com/content/v1/611d0b86ac3d720667702939/a8339211-e56a-4f6e-ae19-1c3498e08a40/Dots_lines_banner-02.png)
Our Programs
Alzheimer’s recognizes no borders - neither can our solutions.
-
Global Cohorts
Diversifying Data to Unlock Breakthroughs
Scientific discovery starts with high-quality data. But 90% of current genetic analysis comes from just 10% of the world's population. DAC is building global cohorts to advance understanding of Alzheimer's among diverse populations. This data will provide the foundation for identifying new biomarkers and developing targeted treatments for people worldwide.
-
Global Clinical Trials
Linking the Best Science to Speed Innovation
Progress against Alzheimer's requires faster, less costly clinical trials. DAC is building a global clinical trial network and technology platform that will link trial sites around the world. This will drive innovation by reducing the time and cost of clinical trials, connecting researchers worldwide and accelerating drug development for people in all communities.
-
Healthcare System Preparedness
Delivering Solutions to People Everywhere
Innovations only make an impact if they reach the people who need them. DAC is investing in healthcare systems and solution providers to improve rates of early, accurate diagnosis and to ensure healthcare systems worldwide are prepared to deliver new innovations that enter the market.
![](https://images.squarespace-cdn.com/content/v1/611d0b86ac3d720667702939/2d91ecb3-0b73-44d9-b6a5-ae453c7fa7ad/Dots_lines_with_curve_banner-02.png)
About Us
Our Beginning
The idea for developing a global mechanism of action was first raised at the 2019 Lausanne Workshop. It was taken forward at the World Economic Forum's Annual Meeting in 2020, where a diverse group of private-sector executives, government leaders and NGOs came together with a singular goal: How can we mount a global response to Alzheimer's by orchestrating game-changing solutions to end the suffering, financial burden and stigma around this disease?
Led by the World Economic Forum (WEF) and The Global CEO Initiative on Alzheimer's Disease (CEOi), the Davos Alzheimer's Collaborative (DAC) seeks to invest over $700 million to accelerate innovation in drug development and transform the way healthcare systems diagnose and treat Alzheimer's for all people in all places.
![](https://images.squarespace-cdn.com/content/v1/611d0b86ac3d720667702939/e872e25f-0d46-4a4e-bf61-b8d2497e403e/Circle_lines-banner-04.png)